What's New

Meeting Highlights
Non-Small-Cell Lung Cancer Highlights from the 5th International Congress on Personalized Therapy for Non-Small-Cell Lung Cancer and Head & Neck Cancer
September 28-29, 2013
FAQ Library
What are the recommended management strategies for patients with low-risk febrile neutropenia?
Christopher R. Flowers, MD

What is the incidence of febrile neutropenia (FN) in patients receiving chemotherapy?
R. Donald Harvey, III, PharmD, FCCP, BCOP

How do you define chemotherapy-related febrile neutropenia?
R. Donald Harvey, III, PharmD, FCCP, BCOP

What are the risk factors for the development of febrile neutropenia (FN) in patients receiving chemotherapy?
R. Donald Harvey, III, PharmD, FCCP, BCOP
CE Education
Reducing the Risk of Oncologic Emergencies: Assessment and Treatment of Severe Neutropenia
Rajni Sinha, MD, MRCP; R. Donald Harvey III, PharmD, FCCP, BCOP
ASCO 2013: Highlights in Hematologic Malignancies
Christopher R. Flowers, MD; Stuart L. Goldberg, MD; Susan M. O'Brien, MD;
Noopur Raje, MD; Donna Reece, MD, Neil P. Shah, MD, PhD; Andrew Zelenetz, MD, PhD
ASCO 2013: Highlights in Prostate Cancer
Tomasz M. Beer, MD; Daniel P. Petrylak, MD; A. Oliver Sartor, MD
Advancements in Lung Cancer: Highlights of the 2013 ASCO Annual Meeting
Laura Q. Chow, MD; Ramaswamy Govindan, MD; H. Kim Lyerly, MD; Giorgio V. Scagliotti, MD, PhD
ASCO 2013: Highlights in Chronic Myelogenous Leukemia
Jorge Eduardo Cortes, MD; Stuart L. Goldberg, MD; Michael J. Mauro, MD